Back to Top

Acute Myeloid Leukemia

Get Help with Your Treatment

Apply Online or call 1-866-316-7263


Program Status

program status icon open

Fully Allocated – We are no longer accepting or processing applications for new or renewal patients.

Maximum Award Level

$12,000 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for the disease named in the assistance program to which he or she is applying.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product.   
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Azacitidine (azacitidine)
  • Cerubidine (daunorubicin hcl)
  • Cladribine (cladribine)
  • Clolar (clofarabine)
  • Cytarabine (cytarabine)
  • Cytarabine (cytarabine/pf)
  • Dacogen (decitabine)
  • Daunorubicin Hcl (daunorubicin hcl)
  • Decitabine (decitabine)
  • Depocyt (cytarabine liposome/pf)
  • Droxia (hydroxyurea)
  • Etopophos (etoposide phosphate)
  • Etoposide (etoposide)
  • Fludarabine Phosphate (fludarabine phosphate)
  • Hycamtin (topotecan hcl)
  • Hydrea (hydroxyurea)
  • Hydroxyurea (hydroxyurea)
  • Idamycin Pfs (idarubicin hcl)
  • Idarubicin Hcl (idarubicin hcl)
  • Methotrexate (methotrexate sodium)
  • Methotrexate (methotrexate sodium/pf)
  • Mitoxantrone Hcl (mitoxantrone hcl)
  • Nexavar (sorafenib tosylate)
  • Otrexup (methotrexate/pf)
  • Rasuvo (methotrexate/pf)
  • Toposar (etoposide)
  • Topotecan Hcl (topotecan hcl)
  • Vidaza (azacitidine)

Diagnosis Codes:

ICD-10: C92.00-C92.02, C92.50-C92.62, C92.A0-C92.A2, C93.00-C93.02, C94.00-C94.22

Related Organizations:

American Cancer Society